) ) ) ) ) Docket DOT-OST-1996-1826 ) (former Docket 48735) ) ) ) ------------------------------~) . . , ~ - :- ,r,: ".

. . BEFORE THE DEPARTMENT OF TRANSPORTATION

. OFFICE OF THE SECRETARY

. . WASlnNGTON, D.C.
Motion of US AIRWAYS, INC. for confidential treatment of documents pursuant to Rule 12 of the Rules of Practice (Schedule B-7 and B-43 ofFonn 41)

MOTION OF US AIRWAYS, INC. FOR CONFIDENTIAL TREATMENT
Communications with respect to this document should be sent to: Howard Kass Vice President
- Regulatory Affairs Abigail Donovan Director, Congressional and Federal Affairs US Airways, Inc. 1401 H Street, NW, Suite 1075 Washington, DC 20005 (202) 326-5153 howard.kass @ usairways.com benjamin.slocum @ usairways.com March 28 , 2014 , !. : i.BEFORE THE DEPARTMENT OF TRANS PORTATION OFFICE OF THE SECRETARY WASHINGTON, D. C.

) ) ) ) ) Docket DOT
- OST
- 1996
- 1826 ) (former Docket 48735) ) ) March 28, 2014 )

------------ -- ---------------- . ) Motion of US AIRWAYS , INC. for conf idential treatment of documents pursuant to Rule 12 of the Rules of Practice (Schedule B- 7 and B
- 43 of Form 4 1 )

MOTION OF US AIRWAYS, INC. FOR CONFIDENTIAL TREATMENT Pursuant to Rule 12 of the Department ' s Rules of Practice (14 C . F.R. § 302.12), US Airway s , Inc. ( " US Airway s " ) hereby requests confidential treatment of certain information contained in Schedule B
- 7
- Airframe and Aircraft Engine Acquisitions and Retirements of US Airways ' Form 41 filing for the quarter ended December 31 , 2013 (" Schedule B
- 7 " ) , and Schedule RA3
- Inventory of Airframes and Aircraft Engines for the year ended December 3 1 , 2013 ("Schedule B
- 43 " ). That filing will be submitted sep arately herewith under seal , marked with a request for confidential treatment pursuant to Rule 12 (§ 302.12) . US Airways requests that these data be withheld from public disclosure for a period of at least ten (10) years from the date of their submission . In support of this request, US Airway s states as follow s: The Freedom of Information Act, 5 U .S . C. § 552(b)(4) , provide s that confidential
commerci al and financial information obtained f rom a private person is exempt from the requirements of public di sclosure. The information for which US Airway s requests confidential treatment is confidential and proprietary commercial and financial information obtained from US Airways , a private party . Moreover, the public release of that information would cause US 1Motion of US Airways,Inc. for Confidential Treatment

Airways substantial competitive and financial injury. Accordingly , the information should be withheld from public disclosure. The information at issue is cost, amortization/depreciation and realization data relating to US Airways' airframes and aircraft engines as of December 31 , 2013. This information is presented in columns 11 , 12, and 13 of Schedule B-7 and in columns 16 through 20 of Schedule B-43. See Exhibit A hereto for a listing of the specific information included in Schedule B-7 and Schedule B-43 for which confidential treatment is requested. In addition to filing Schedule B-7 and Schedule B-43 under seal, US Airways is submitting to the Office of Aviation Analysis redacted copies of Schedule B-7 and Schedule B-43 , available for public inspection , that omit the information for which confidential treatment is requested. The Department has previously determined that the confidential and competitively sensitive data contained in US Airways ' Schedules B-7 and B-43 are entitled to confidential treatment. By letter of James W. Mitchell , Director, Office of Airline Statistics , the Department granted prior US Airways ' requests for confidential treatment of this same information for earlier reporting periods and ruled that it be withheld from public disclosure for a period of ten (10) years. The Department's reasoning applies with equal force to US Airways' present motion and submission.

2Motion of US Airways, Inc. for Confidential Treatment

WHEREFORE , US Airway s , Inc. respectfully requests that the confidenti al information contained in its Schedule B-7 and Schedule B-43 detailed above be withheld f rom public disclosure for at least ten (10) years. Respectfully submitted ,

Howard Kass Vice President
- Regulatory Affairs Abigail Donov an Director, Congressional and Federal Affairs US Airways, Inc. 1401 H Street, NW , Suite 1075 Washington , DC 20005 (202) 326-5153 howard.kass@usairways.com benjamin.slocum @ usairways.com March 28 , 2014

3EXHIBIT A

Listing of Confidential Information in US Airways, Inc.' s Form 41 Filing Schedule B-7: TitlelDescription Location in Document Number of Pages Cost Column (11) 3 Depreciated Cost or Column (12) 3 Amortized Value Realization Column (13) 3

Schedule B-43: TitlelDescription Location in Document Number of Pages Acquired Cost or Capital Column (16) 7 Value Allowance for Depreciation or Column (17) 7 Amortization Depreciation Cost or Column (18) 7 Amortized Value Estimated Residual Value Column (19) 7 Estimated Depreciation or Column (20) 7 Amortization Life (Months)